Clinical Trials on Multiple Sclerosis Brain Lesion
Total 3915 results
-
Stem Cell Medicine Ltd.WithdrawnSecondary Progressive Multiple Sclerosis (SPMS)Israel
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple Sclerosis (SPMS)Japan
-
Novartis PharmaceuticalsTerminatedDepression | Relapsing-remitting Multiple SclerosisGermany
-
Amanda IrishCompletedMultiple Sclerosis, Relapsing-remittingUnited States
-
University of IowaDJO Incorporated; Direct MS Canada; Pinnaclife Inc.; TZ Press, LLCCompletedMultiple SclerosisUnited States
-
National Institute of Neurological Disorders and...Terminated
-
Amphia HospitalSanofi; TEVA PharmachemieUnknown
-
University Hospital Hradec KraloveRecruitingBrain Damage | Hydrocephalus, Normal Pressure | Biochemical Lesions Head RegionCzechia
-
SanofiRecruitingMultiple SclerosisUnited States, Canada, Australia, Puerto Rico, United Kingdom
-
University of CalgaryRecruiting
-
Danish Research Centre for Magnetic ResonanceScleroseforeningen; Danish Multiple Sclerosis CenterRecruitingPrimary Progressive Multiple SclerosisDenmark
-
Novartis PharmaceuticalsCompletedMayzent (Siponimod) Onboarding of Secondary Progressive Multiple Sclerosis (SPMS) Patients With MSGoSecondary Progressive Multiple SclerosisAustralia
-
SanofiActive, not recruitingSecondary Progressive Multiple SclerosisUnited States, Argentina, Belgium, Canada, Czechia, France, Germany, Greece, India, Israel, Netherlands, Norway, Portugal, Turkey, United Kingdom, Japan, Austria, Bulgaria, China, Denmark, Finland, Italy, Lithuania, Poland, Romania, Russian... and more
-
University of NottinghamNottingham University Hospitals NHS TrustCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
University College, LondonUniversity of Leeds; University of Sheffield; Medical Research Council; Queen Mary... and other collaboratorsCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
Isfahan University of Medical SciencesCompletedSecondary Progressive Multiple SclerosisIran, Islamic Republic of
-
BiogenTerminatedSecondary Progressive Multiple SclerosisUnited States, Finland, Italy, Spain, Canada, France, Israel, Sweden, Netherlands, Belgium, Poland, United Kingdom, Czechia, Denmark, Russian Federation, Germany, Ireland
-
Merck KGaA, Darmstadt, GermanyMerck Quimica Argentina S.A.I.CCompletedMultiple Sclerosis, Relapsing RemittingArgentina
-
Eli Lilly and CompanyBioMS Technology Corp.TerminatedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Latvia, Spain, Sweden, United Kingdom, Germany, Netherlands
-
Eli Lilly and CompanyBioMS Technology Corp.CompletedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Germany, Latvia, Netherlands, Spain, Sweden, United Kingdom
-
Wyeth is now a wholly owned subsidiary of PfizerTerminatedSecondary Progressive Multiple SclerosisGermany
-
BiogenCompletedDoes Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a? (FLAIR)Relapsing Remitting Multiple SclerosisBelgium, Luxembourg, United Kingdom
-
Subtle MedicalBayerEnrolling by invitation
-
Assistance Publique - Hôpitaux de ParisRoche Pharma AG; Institut du Cerveau et de la Moelle épinièreRecruitingMultiple Sclerosis | Relapse | Primary Progressive Multiple SclerosisFrance
-
Rennes University HospitalRecruiting
-
Novartis PharmaceuticalsAvailable
-
University of VirginiaNational Multiple Sclerosis SocietyUnknownClinically Isolated Syndrome | Relapsing Remitting Multiple SclerosisUnited States
-
Innate ImmunotherapeuticsSyneos HealthCompletedSecondary Progressive Multiple SclerosisNew Zealand, Australia
-
BiogenTerminatedMultiple Sclerosis, Secondary ProgressiveUnited States, Poland, Belgium, Slovakia, Czech Republic, Netherlands
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis, Relapsing-remittingArgentina
-
BiogenWithdrawn
-
University College London HospitalsCompletedSecondary Progressive Multiple SclerosisUnited Kingdom
-
Tuba MadenCompletedMultiple Sclerosis | Postural Balance | Cervical Region Disorder Nos | Muscle Tonus | ProprioceptionTurkey
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited Kingdom
-
BiogenElan PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited States, Germany, Spain
-
Neuromed IRCCSUniversity of Rome Tor VergataNot yet recruitingHealthy | Neuromyelitis Optica | Relapsing-Remitting Multiple Sclerosis (RRMS)Italy
-
Haukeland University HospitalRecruitingProgressive Multiple Sclerosis | Multiple SclerosisNorway
-
University Hospital, GhentUniversity Ghent; BytefliesRecruitingProgressive Multiple SclerosisBelgium
-
Hasselt UniversityRevalidatie & MS Centrum Overpelt; National MS Center MelsbroekRecruitingProgressive Multiple Sclerosis | Multiple SclerosisBelgium
-
University Hospital, BordeauxRoche Pharma AGRecruitingMultiple Sclerosis, Primary ProgressiveFrance
-
Duke UniversityCompletedPrimary Progressive Multiple SclerosisUnited States
-
Hoffmann-La RocheActive, not recruitingMultiple SclerosisBelgium, United Kingdom, Netherlands, Serbia, Poland, Slovakia, Bulgaria, Turkey, Brazil, Italy, Russian Federation, Spain, Austria, Colombia, Romania, Kuwait, Chile, Dominican Republic, Egypt, Montenegro, Panama, Paraguay, Portugal, ... and more
-
State University of New York at BuffaloGenentech, Inc.Active, not recruitingPrimary Progressive Multiple SclerosisUnited States
-
State University of New York at BuffaloGenentech, Inc.Active, not recruitingPrimary Progressive Multiple SclerosisUnited States
-
Terry L. WahlsActive, not recruitingClinically Isolated Syndrome | Relapsing Remitting Multiple SclerosisUnited States
-
Hoffmann-La RocheActive, not recruitingMultiple SclerosisUnited States, Brazil, Poland, United Kingdom, Turkey, Bulgaria, Belgium, Canada, Denmark, France, Germany, Greece, Hungary, Italy, Peru, Portugal, Russian Federation, Spain, Switzerland, Ukraine, Mexico, Argentina
-
Hoffmann-La RocheCompletedMultiple Sclerosis, Primary ProgressiveUnited States, Canada, Australia, Hungary, Brazil, Finland, Italy, Germany, Romania, Lithuania, France, Greece, Peru, Portugal, Spain, Switzerland, Bulgaria, Ukraine, Israel, Poland, Austria, New Zealand, Netherlands, Belgium, Mexico, United... and more
-
Marmara UniversityCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis RelapseTurkey
-
University Hospital, Clermont-FerrandMedDay Pharmaceuticals SA; OFSEP (Observatoire Français de la Sclérose en Plaques) and other collaboratorsUnknownProgressive Multiple SclerosisFrance
-
Lille Catholic UniversityBayerCompletedPrimary Progressive Multiple SclerosisFrance